Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1998
10/28/1998EP0873355A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione
10/28/1998EP0873340A1 Heterocyclic substituted cyclopentane compounds
10/28/1998EP0873339A1 Purine and guanine derivatives as pnp inhibitors
10/28/1998EP0873338A1 Quinoline derivatives as type iv phosphodiesterase inhibitors
10/28/1998EP0873336A1 Antagonists of gonadotropin releasing hormone
10/28/1998EP0873335A1 HETEROCYCLYL-CONDENSED BENZOYLGUANIDINES, THEIR PRODUCTION AND USE AS INHIBITORS OF THE CELLULAR Na+/H+-ANTIPORTER
10/28/1998EP0873331A1 Benzofuran carboxamides and sulphonamides
10/28/1998EP0873330A1 Diarylalkenylamine derivatives
10/28/1998EP0873329A1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
10/28/1998EP0873320A1 Piperazine derivatives as tachykinin antagonists
10/28/1998EP0873312A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
10/28/1998EP0873311A1 Tri-aryl ethane derivatives as pde iv inhibitors
10/28/1998EP0873310A1 Diphenyl pyridyl ethane derivatives as pde iv inhibitors
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0873304A1 Metalloproteinase inhibitors
10/28/1998EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998EP0873134A1 Aqueous prolonged release formulation
10/28/1998EP0873123A1 Inhibitors of protein isoprenyl transferases
10/28/1998EP0873118A1 Transdermal administration of ropinirole and analogs thereof
10/28/1998EP0873051A1 Modulation of calcium channels
10/28/1998EP0873049A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
10/28/1998EP0649418B1 7-(2-aminoethyl)-benzothiazolones
10/28/1998EP0476016B1 CNS active 8-heterocyclyl-2-aminotetralin derivatives
10/28/1998CN1197450A Esters and amides as PLA2 inhibitors
10/28/1998CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/28/1998CN1197076A Steroid compounds having contraceptive and anti-osteoporosis activity
10/28/1998CN1197067A New naphthylpiperazine derivatives
10/28/1998CN1196952A Saussurea involucrata and safflower wine and its prepn. method
10/28/1998CN1040432C Spiro piperdines derivatives and its prepn. and applications
10/28/1998CA2231746A1 A human sodium dependent phosphate transporter (ipt-1)
10/27/1998US5827898 Use of bisphenolic compounds to treat type II diabetes
10/27/1998US5827897 Insulin-resistance in a mammal treated by administering a synergistic mixture of a retinoid and a fatty acid; antidiabetic agents
10/27/1998US5827891 For treatment of aids, blocking replication of hiv virus
10/27/1998US5827890 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
10/27/1998US5827887 Biphenyl compounds
10/27/1998US5827874 Rheumatic, nonrheumatic and postoperative posttraumatic pain
10/27/1998US5827871 Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof
10/27/1998US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998US5827859 HIV protease inhibitors
10/27/1998US5827858 Administered to treat aids
10/27/1998US5827849 Cyclic dericatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/27/1998US5827842 14α, 17α-C2 -bridged norprogesterone derivatives
10/27/1998US5827819 Pharmaceutical composition comprising a psychotropic, neurotropic or neurological drug, a polar lipid carrier, two linker functional groups and a spacer; facilitates entry of drugs into cells and tissues
10/27/1998US5827740 A mixture of glucocorticoids and an adenosine monophosphates inducing the fat cells by cell differentiation
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/27/1998CA2102179C Quinuclidine derivatives
10/25/1998CA2207753A1 Modulators of multi-drug resistances
10/22/1998WO1998046746A1 Extracellular/epidermal growth factor like protein
10/22/1998WO1998046743A1 Novel ldl-receptor
10/22/1998WO1998046731A1 Inhibitors for urokinase receptor
10/22/1998WO1998046643A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
10/22/1998WO1998046638A1 A novel th2-specific gene
10/22/1998WO1998046635A1 GnRH ANTAGONISTS
10/22/1998WO1998046634A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6
10/22/1998WO1998046633A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
10/22/1998WO1998046632A2 Inhibitors for urokinase receptor
10/22/1998WO1998046624A1 A method for stimulating red blood cell production
10/22/1998WO1998046611A1 Compounds
10/22/1998WO1998046609A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
10/22/1998WO1998046606A1 Novel compounds
10/22/1998WO1998046605A1 5,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds and their use as adenosine kinase inhibitors
10/22/1998WO1998046604A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998WO1998046603A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998WO1998046598A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
10/22/1998WO1998046595A1 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists
10/22/1998WO1998046591A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046589A2 Indazole amide compounds as serotoninergic agents
10/22/1998WO1998046585A1 Inhibitors of cholesterol esterase
10/22/1998WO1998046582A1 Protease inhibitors
10/22/1998WO1998046576A2 Halo-alkoxycarbonyl prodrugs
10/22/1998WO1998046574A1 Pyridazine and phthalazine derivatives, process of their preparation and their use as anticonvulsants
10/22/1998WO1998046570A1 Substituted heteroaromatic 5-ht1f agonists
10/22/1998WO1998046563A1 Metalloproteinase inhibitors
10/22/1998WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998WO1998046245A1 Method and composition for treating sleep apnea
10/22/1998WO1998046244A1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
10/22/1998WO1998046223A1 Retinoid antagonists for prevention of surgical adhesions
10/22/1998WO1998046204A1 Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
10/22/1998WO1998046076A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
10/22/1998WO1998036068A3 Human p24 vesicle proteins
10/22/1998WO1998032463A3 Lyophilizate of lipid complex of water insoluble porphyrins
10/22/1998DE19745792C1 Isolation of wound healing regulatory factors
10/22/1998DE19716713A1 Arzneimittel, enthaltend Ibuprofenthioester als Hemmer der Nf-kappaB abhängigen Bildung von Mediatoren von Entzündung und Schmerz A drug containing Ibuprofenthioester dependent as inhibitors of Nf-kappaB formation of mediators of inflammation and pain
10/22/1998CA2288284A1 Use of at least one irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
10/22/1998CA2288171A1 Pyridazine and phthalazine derivatives, process of their preparation and their use as anticonvulsants
10/22/1998CA2287518A1 A novel th2-specific gene
10/22/1998CA2287465A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998CA2287085A1 Tumor necrosis factor receptor related proteins tango-63d and tango-63e
10/22/1998CA2286909A1 5,7-disubstituted 4-aminopyrido¬2,3-d|pyrimidine compounds and their use as adenosine kinase inhibitors
10/22/1998CA2286789A1 Compounds
10/22/1998CA2286592A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998CA2286478A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
10/22/1998CA2286351A1 Extracellular/epidermal growth factor like protein
10/22/1998CA2286332A1 Inhibitors for urokinase receptor
10/22/1998CA2286261A1 Retinoid antagonists for prevention of surgical adhesions
10/22/1998CA2286181A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
10/22/1998CA2286078A1 Novel compounds
10/22/1998CA2285610A1 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists
10/22/1998CA2285603A1 Substituted heteroaromatic 5-ht1f agonists
10/22/1998CA2285601A1 Protease inhibitors
1 ... 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 ... 1564